Quarterly Updates30 May 2026, 09:31 am
Fischer Medical Ventures: FY26 Revenue ₹1739.18 Lakhs
AI Summary
Fischer Medical Ventures Ltd's board approved the audited financial results for the year ended March 31, 2026. Key highlights include a final dividend recommendation of ₹0.05 per equity share and the appointment of S. Ramanand Aiyer & Co. as internal auditors for FY 2026-27. The company reported revenue from operations of ₹1739.18 lakhs and a loss before tax of ₹1050.58 lakhs for the year ended March 31, 2026.
Key Highlights
- Fischer Medical Ventures declares a final dividend of ₹0.05 per equity share for FY26.
- S. Ramanand Aiyer & Co. appointed as internal auditors for the financial year 2026-27.
- The company's revenue from operations stood at ₹1739.18 lakhs for FY26.
- The company reported a loss before tax of ₹1050.58 lakhs for the year ended March 31, 2026.
- Auditors M/s. Bilimoria Mehta & Co. issued an unmodified opinion on the standalone and consolidated financial statements for FY26.
Price Impact
More from FISCHER